---
category: news
title: "Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target"
excerpt: "Kiromic Biopharma, Inc. (Nasdaq: KRBP), a target discovery and gene-editing company utilizing artificial intelligence and proprietary neural network platform with a therapeutic focus on immuno-oncology,"
publishedDateTime: 2021-01-05T02:42:00Z
originalUrl: "https://apnews.com/press-release/business-wire/science-business-government-regulations-coronavirus-pandemic-ovarian-cancer-fd1147f580d54e34b67ae7eb6f2ebcb4"
webUrl: "https://apnews.com/press-release/business-wire/science-business-government-regulations-coronavirus-pandemic-ovarian-cancer-fd1147f580d54e34b67ae7eb6f2ebcb4"
type: article
quality: 15
heat: 15
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "jv48rdjqnoc+qDsnIpkOuLCFIuVqa4C4DDUWGxi7c/SZIlwzTZRPowuGJ9EftdoNp4X5r/IivJOfaAuHW/MUs0X7l+Onfv6dhf8Zr8mSpZkWI3/GLWr/2EDBkG1yC4FgyUeLfUantqpmkU0t7X6EigOTJBa0IcvEfcLlNxMwzR6MixYrpU0iCJc3MpmVK/ykFn+KZ2samIxa4IVL+Fj4GuQWK/VDnGwc39M/P+wx8ntcx3TvRPSwxczTL5Y+lvF8K8BEcrfXMlVCiMAcm+UoqNYvA4ZkVBZus//TRUg2j8qEYuPUGYLJQ4CEZrsE30MUjPW7hep2rjBiIx/rUoZeG23aBir5qZKZ5Z+b0Q7l6rk=;c/d20K1tCr2+R4zuRUlLxQ=="
---

